Ignite Creation Date:
2024-05-06 @ 4:05 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04867616
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-13
First Post:
2021-04-27
Brief Title:
A Study to Test the Efficacy Safety and Tolerability of Bepranemab UCB0107 in Patients With Mild Cognitive Impairment or Mild Alzheimers Disease AD
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-09
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-07-28
Completion Date Type:
ESTIMATED
First Submit Date:
2021-04-27
First Submit QC Date:
April 27 2021
Study First Post Date:
2021-04-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-12
Last Update Post Date:
2024-06-13
Last Update Post Date Type:
ACTUAL